Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
British Journal of Cancer
|
December 15, 2004
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
C Mascaux, N Iannino, B Martin, et al.
British Journal of Cancer
|
July 3, 2003
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
B Martin, M Paesmans, T Berghmans, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 7, 2013
Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study
T Berghmans, L Ameye, L Willems, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 2025
Real-world effectiveness and tolerability of sotorasib in patients with KRAS G12C-mutated metastatic non-small cell lung cancer: The IFCT-2102 Lung KG12Ci study
M Wislez, C Mascaux, J Cadranel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2025
Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
A Zer, M-J Ahn, F Barlesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 13, 2023
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1
B Besse, E Felip, R Garcia Campelo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 14, 2026
Four-Year outcomes of first-line Nivolumab plus ipilimumab for 6 months versus continuation in patients with advanced non-small-cell lung cancer Results of the randomized IFCT-1701 "DICIPLE" Phase III trial
G Zalcman, A Madroszyk, E Guenzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2019
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
J Mazieres, A Drilon, A Lusque, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
British Journal of Cancer
|
December 15, 2004
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
C Mascaux, N Iannino, B Martin, et al.
British Journal of Cancer
|
July 3, 2003
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
B Martin, M Paesmans, T Berghmans, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 7, 2013
Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study
T Berghmans, L Ameye, L Willems, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 2025
Real-world effectiveness and tolerability of sotorasib in patients with KRAS G12C-mutated metastatic non-small cell lung cancer: The IFCT-2102 Lung KG12Ci study
M Wislez, C Mascaux, J Cadranel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2025
Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
A Zer, M-J Ahn, F Barlesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 13, 2023
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1
B Besse, E Felip, R Garcia Campelo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 14, 2026
Four-Year outcomes of first-line Nivolumab plus ipilimumab for 6 months versus continuation in patients with advanced non-small-cell lung cancer Results of the randomized IFCT-1701 "DICIPLE" Phase III trial
G Zalcman, A Madroszyk, E Guenzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2019
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
J Mazieres, A Drilon, A Lusque, et al.
Page
of 5